Ping An Good Doctor and Roche China Co-Launch the 'Pharma-Insurance-Healthcare Ecosystem Alliance' at CIIE

On November 7, 2025, at the 8th China International Import Expo, PINGAN GOOD DOCTOR (Ping An Health Internet Company Limited) and partners including Roche Pharmaceuticals China jointly launched the “Pharmaceutical-Insurance Ecosystem Alliance.” Corporate leaders in attendance included He Mingke, CEO of PINGAN GOOD DOCTOR, and Luo Dan, Vice President of National Market Access at Roche Pharmaceuticals China. It is reported that the parties will strengthen in-depth cooperation in building a health management service system covering the full cycle of “prevention, diagnosis, treatment, and rehabilitation.” This initiative is expected to continuously improve patient access to innovative drugs and payment flexibility, providing users with a smarter and more convenient new health management experience.

Roundtable On-Site

Finance and healthcare/elderly care are the two largest, fastest-growing, and most synergistic industries in China’s future. As Chinese households accumulate increasing wealth, residents’ awareness of health management and their willingness to pay for health services are rising rapidly. However, from a global perspective, China’s per capita healthcare expenditure remains far below the levels seen in developed countries. Furthermore, with the intensifying aging of the domestic population, the wave of the “silver economy” has arrived, driving a sharp increase in demand for elderly care services.

The “14th Five-Year Plan for Digital Economy Development” explicitly mentioned “accelerating the development of digital health services” for the first time, clearly establishing digital health as a vital component of the digital economy from a policy perspective. The proposals for the 15th Five-Year Plan further emphasize that “digital health is one of the driving forces in building a modern healthcare system with Chinese characteristics.” Remote consultations, online health counseling, smart hospitals, and wearable device monitoring are becoming the norm, enabling “data to travel more so patients have to run less,” thereby significantly enhancing the accessibility and convenience of medical services. As the flagship of Ping An Group’s healthcare and elderly care ecosystem, PINGAN GOOD DOCTOR has leveraged its platform advantages and technology-driven approach in recent years to transform medical services from “passive treatment” to “proactive management.” It is committed to providing patients with full-cycle health management services spanning disease prevention, diagnosis, treatment, and rehabilitation.

He Mingke, CEO of PINGAN GOOD DOCTOR, stated on-site that while continuously integrating online and offline service capabilities and expanding its “Four Arrivals” service network, the company is accelerating AI-driven empowerment, increasingly applying it across full-scenario medical, health, and elderly care services. Patients can better experience a full-lifecycle health journey characterized by “proactive health management, rapid consultation for minor illnesses, precise referral for serious conditions, and comprehensive chronic disease management.” For example, PINGAN GOOD DOCTOR’s family doctors proactively track patients’ treatment progress, providing 24/7 medication reminders, symptom monitoring, report analysis, and rehabilitation progress tracking to ensure the continuity and stability of treatment outcomes. With breakthroughs in self-developed AI capabilities and the successful implementation of a “data + model + scenario” closed loop, the accuracy rate of PINGAN GOOD DOCTOR’s multidisciplinary team (MDT) treatment plans for complex diseases has risen year by year to nearly 90%. As ordinary patients, individuals can now say goodbye to the long-standing challenges of slow, cumbersome, and ineffective medical consultations with just a few taps on their screens.

He Mingke, CEO of PINGAN GOOD DOCTOR

In recent years, PINGAN GOOD DOCTOR and Roche China have established a solid foundation for collaboration in areas such as innovative influenza medications and specialized oncology drugs. Moving forward, the two parties will continue to deepen their cooperation in oncology and innovative pharmaceuticals, jointly exploring more comprehensive digital health management solutions.

It is reported that PINGAN GOOD DOCTOR has been deeply engaged in the field of medical, health, and elderly care services for many years, accumulating extensive experience in technology empowerment, user scale, and high-quality service. The establishment of the “Pharmaceutical-Medical-Insurance Ecosystem Alliance” with Roche China marks a more solid step taken by both parties in building a new ecosystem for healthcare. This is not merely a business collaboration but also an active implementation of the “Healthy China 2030” strategy. Leveraging the international platform of the China International Import Expo (CIIE), PINGAN GOOD DOCTOR will join hands with more industry partners to jointly promote the implementation of the Outline of the “Healthy China 2030” Plan.